Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer

被引:36
作者
Miao, Ruizhong [1 ]
Badger, Taylor C. [2 ]
Groesch, Kathleen [3 ,4 ]
Diaz-Sylvester, Paula L. [3 ,4 ]
Wilson, Teresa [3 ,4 ]
Ghareeb, Allen [3 ,4 ]
Martin, Jongjin Anne [4 ]
Cregger, Melissa [5 ,6 ]
Welge, Michael [7 ]
Bushell, Colleen [8 ]
Auvil, Loretta [7 ]
Zhu, Ruoqing [9 ]
Brard, Laurent [4 ,10 ]
Braundmeier-Fleming, Andrea [2 ,4 ,10 ]
机构
[1] Univ Virginia, Dept Stat, Charlottesville, VA USA
[2] SIU Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA
[3] SIU Sch Med, Clin Res Ctr, Springfield, IL USA
[4] SIU Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA
[5] Oak Ridge Natl Lab, Oak Ridge, TN USA
[6] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA
[7] Univ Illinois, Natl Ctr Supercomp Applicat, Champaign, IL USA
[8] Univ Illinois, Inst Appl Res, Champaign, IL USA
[9] Univ Illinois, Dept Stat, Champaign, IL 61820 USA
[10] Simmons Canc Inst SIU, Springfield, IL 62702 USA
来源
PLOS ONE | 2020年 / 15卷 / 01期
关键词
REGRESSION SHRINKAGE; GUT MICROBIOTA; BIOMARKERS; CA-125; SERUM; FLUID; HE-4; CULDOCENTESIS; PREDICTION; CARCINOMA;
D O I
10.1371/journal.pone.0227707
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epithelial ovarian cancer (OC) is the most deadly cancer of the female reproductive system. To date, there is no effective screening method for early detection of OC and current diagnostic armamentarium may include sonographic grading of the tumor and analyzing serum levels of tumor markers, Cancer Antigen 125 (CA-125) and Human epididymis protein 4 (HE4). Microorganisms (bacterial, archaeal, and fungal cells) residing in mucosal tissues including the gastrointestinal and urogenital tracts can be altered by different disease states, and these shifts in microbial dynamics may help to diagnose disease states. We hypothesized that the peritoneal microbial environment was altered in patients with OC and that inclusion of selected peritoneal microbial features with current clinical features into prediction analyses will improve detection accuracy of patients with OC. Blood and peritoneal fluid were collected from consented patients that had sonography confirmed adnexal masses and were being seen at SIU School of Medicine Simmons Cancer Institute. Blood was processed and serum HE4 and CA-125 were measured. Peritoneal fluid was collected at the time of surgery and processed for Next Generation Sequencing (NGS) using 16S V4 exon bacterial primers and bioinformatics analyses. We found that patients with OC had a unique peritoneal microbial profile compared to patients with a benign mass. Using ensemble modeling and machine learning pathways, we identified 18 microbial features that were highly specific to OC pathology. Prediction analyses confirmed that inclusion of microbial features with serum tumor marker levels and control features (patient age and BMI) improved diagnostic accuracy compared to currently used models. We conclude that OC pathogenesis alters the peritoneal microbial environment and that these unique microbial features are important for accurate diagnosis of OC. Our study warrants further analyses of the importance of microbial features in regards to oncological diagnostics and possible prognostic and interventional medicine.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Ovarian Cancer: Potential biomarkers and nanotechnology based diagnostic tools
    Sounkaria, Shruti
    Chandra, Prakash
    ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY, 2021, 12 (03)
  • [2] Inhibin as a diagnostic marker for ovarian cancer
    Robertson, David N.
    Pruysers, Enid
    Jobling, Tom
    CANCER LETTERS, 2007, 249 (01) : 14 - 17
  • [3] Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer
    Wu, Xiaohua
    Li, Dongxiu
    Liu, Liping
    Liu, Bojun
    Liang, Hongxia
    Yang, Bo
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (06) : 1309 - 1314
  • [4] PROSTASIN, A POTENTIAL TUMOR MARKER IN OVARIAN CANCER- A PILOT STUDY
    Costa, Fernanda Pires
    Batista Junior, Eraldo Luis
    Zelmanowicz, Alice
    Svedman, Christer
    Devenz, Gabriela
    Alves, Silvana
    Martins da Silva, Andrea Simoes
    Garicochea, Bernardo
    CLINICS, 2009, 64 (07) : 641 - 644
  • [5] Tumor Markers and Their Diagnostic Significance in Ovarian Cancer
    Matsas, Alkis
    Stefanoudakis, Dimitrios
    Troupis, Theodore
    Kontzoglou, Konstantinos
    Eleftheriades, Makarios
    Christopoulos, Panagiotis
    Panoskaltsis, Theodoros
    Stamoula, Eleni
    Iliopoulos, Dimitrios C.
    LIFE-BASEL, 2023, 13 (08):
  • [6] Osteopontin as a tumor marker in ovarian cancer
    Rani, Shikha
    Sehgal, Alka
    Kaur, Jasbinder
    Pandher, Dilpreet Kaur
    Punia, Rajpal Singh
    JOURNAL OF MID-LIFE HEALTH, 2022, 13 (03) : 200 - 205
  • [7] Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
    Fujiwara, Hiroyuki
    Suzuki, Mitsuaki
    Takeshima, Nobuhiro
    Takizawa, Ken
    Kimura, Eizo
    Nakanishi, Toru
    Yamada, Kyosuke
    Takano, Hirokuni
    Sasaki, Hiroshi
    Koyama, Koji
    Ochiai, Kazunori
    TUMOR BIOLOGY, 2015, 36 (02) : 1045 - 1053
  • [8] Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors
    Chen, Yong-ning
    Ma, Fei
    Zhang, Ya-di
    Chen, Li
    Li, Chan-yuan
    Gong, Shi-peng
    CURRENT MEDICAL SCIENCE, 2020, 40 (01) : 184 - 191
  • [9] Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study
    Bel'skaya, Lyudmila V.
    Sarf, Elena A.
    Loginova, Alexandra I.
    Vyushkov, Dmitry M.
    Choi, En Djun
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (06) : 5084 - 5098
  • [10] Thrombopoietin: a novel candidate tumor marker for the diagnosis of ovarian cancer
    Mermer, Timucin
    Terek, Mustafa Cosan
    Zeybek, Burak
    Ergenoglu, Ahmet Mete
    Yeniel, Ahmet Ozgur
    Ozsaran, Aydin
    Zekioglu, Osman
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (02) : 86 - 90